Annual Cash & Cash Equivalents
$2.82 M
-$8.59 M-75.28%
December 1, 2023
Summary
- As of March 10, 2025, BIAF annual cash & cash equivalents is $2.82 million, with the most recent change of -$8.59 million (-75.28%) on December 1, 2023.
- During the last 3 years, BIAF annual cash & cash equivalents has risen by +$2.74 million (+3295.43%).
- BIAF annual cash & cash equivalents is now -75.28% below its all-time high of $11.41 million, reached on December 31, 2022.
Performance
BIAF Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$756.60 K
-$44.70 K-5.58%
September 1, 2024
Summary
- As of March 10, 2025, BIAF quarterly cash and cash equivalents is $756.60 thousand, with the most recent change of -$44.70 thousand (-5.58%) on September 1, 2024.
- Over the past year, BIAF quarterly cash and cash equivalents has dropped by -$1.70 million (-69.16%).
- BIAF quarterly cash and cash equivalents is now -94.39% below its all-time high of $13.50 million, reached on September 30, 2022.
Performance
BIAF Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BIAF Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -75.3% | -69.2% |
| 3 y3 years | +3295.4% | -69.2% |
| 5 y5 years | +3295.4% | -69.2% |
BIAF Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -75.3% | +107.4% | -94.4% | +252.9% |
| 5 y | 5-year | -75.3% | +3295.4% | -94.4% | +252.9% |
| alltime | all time | -75.3% | +3295.4% | -94.4% | +252.9% |
BioAffinity Technologies Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $756.60 K(-5.6%) |
| Jun 2024 | - | $801.30 K(-67.3%) |
| Mar 2024 | - | $2.45 M(-13.1%) |
| Dec 2023 | $2.82 M(-75.3%) | $2.82 M(-37.4%) |
| Sep 2023 | - | $4.51 M(-45.5%) |
| Jun 2023 | - | $8.28 M(-15.3%) |
| Mar 2023 | - | $9.77 M(-14.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $11.41 M(+738.9%) | $11.41 M(-15.4%) |
| Sep 2022 | - | $13.50 M(+6195.7%) |
| Jun 2022 | - | $214.40 K(-79.1%) |
| Mar 2022 | - | $1.03 M(-24.4%) |
| Dec 2021 | $1.36 M(+1537.3%) | - |
| Dec 2021 | - | $1.36 M |
| Dec 2020 | $83.10 K | - |
FAQ
- What is bioAffinity Technologies annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for bioAffinity Technologies?
- What is bioAffinity Technologies annual cash & cash equivalents year-on-year change?
- What is bioAffinity Technologies quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for bioAffinity Technologies?
- What is bioAffinity Technologies quarterly cash and cash equivalents year-on-year change?
What is bioAffinity Technologies annual cash & cash equivalents?
The current annual cash & cash equivalents of BIAF is $2.82 M
What is the all time high annual cash & cash equivalents for bioAffinity Technologies?
bioAffinity Technologies all-time high annual cash & cash equivalents is $11.41 M
What is bioAffinity Technologies annual cash & cash equivalents year-on-year change?
Over the past year, BIAF annual cash & cash equivalents has changed by -$8.59 M (-75.28%)
What is bioAffinity Technologies quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BIAF is $756.60 K
What is the all time high quarterly cash and cash equivalents for bioAffinity Technologies?
bioAffinity Technologies all-time high quarterly cash and cash equivalents is $13.50 M
What is bioAffinity Technologies quarterly cash and cash equivalents year-on-year change?
Over the past year, BIAF quarterly cash and cash equivalents has changed by -$1.70 M (-69.16%)